Himadri Speciality Chemical Limited (HSCL)
🎯 Key Takeaways
- Himadri Speciality Chemical Limited is transitioning from a mature carbon black producer to a growth-oriented specialty chemicals player with strategic investments in high-value segments like EVs and semiconductors. Management is executing a multi-phase capex program to expand anthraquinone/carbazole, launch India's first carbon nanotube (CNT) facility, and scale super speciality carbon black capacity, all aimed at reducing import dependency and capturing emerging market opportunities.
- Revenue grew 0.3% QoQ to ₹1,141 in Q3FY25.
- ⚠️ Execution risk around timely commissioning of the CNT and super speciality carbon black facilities by FY27-FY28 remains a key monitorable, as delays c
📖 The Story
Himadri Speciality Chemical Limited is transitioning from a mature carbon black producer to a growth-oriented specialty chemicals player with strategic investments in high-value segments like EVs and semiconductors. Management is executing a multi-phase capex program to expand anthraquinone/carbazole, launch India's first carbon nanotube (CNT) facility, and scale super speciality carbon black capacity, all aimed at reducing import dependency and capturing emerging market opportunities.
📰 What's Happening
The board approved three major capex projects in Q1 FY27: Rs 128 crores for anthraquinone/carbazole expansion to 5300 MTPA by FY28, Rs 70 crores for India's first in-house CNT facility (200 MT capacity by FY27), and Rs 170 crores for super speciality carbon black expansion to 6000 MTPA by FY28. These initiatives are explicitly designed to serve high-growth sectors including electric vehicles and semiconductors, with phased commissioning expected through Q4 FY27 and FY28. The investments are fully funded through internal accruals without diluting capacity.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Q4FY23 | Q1FY24 | Q2FY24 | Q3FY24 | Q4FY24 | Q1FY25 | Q2FY25 | Q3FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,029 | 951 | 1,005 | 1,053 | 1,177 | 1,200 | 1,137 | 1,141 |
| Operating Profit | 136 | 144 | 167 | 184 | 192 | 205 | 222 | 233 |
| OPM % | 12.2% | 14.1% | 15.7% | 16.5% | 15.3% | 16.0% | 18.3% | 19.4% |
| Net Profit | 76 | 86 | 101 | 109 | 115 | 123 | 136 | 141 |
| EPS | ₹1.80 | ₹1.99 | ₹2.29 | ₹2.47 | ₹2.41 | ₹2.49 | ₹2.74 | ₹2.88 |
Operating performance shows steady improvement in profitability, with Q1 FY27 unaudited results reporting ₹228.43 crores net profit — up significantly from ₹141 crores in Q3 FY25 and ₹123 crores in Q1 FY25. Operating margins have expanded from 14.1% in Q1 FY24 to 19.4% in Q3 FY25, reflecting operational efficiency gains and favorable product mix. Revenue remains relatively stable around ₹1,100-1,200 crores quarterly, indicating execution focus on margin enhancement rather than top-line growth.
🔮 Management Outlook & What's Next
Management explicitly stated that the capex projects target import reduction and positioning the company in high-growth EV and semiconductor markets, with phased capacity additions scheduled through Q4 FY28. The board emphasized that all expansions are funded internally, signaling confidence in cash flow generation to support growth without external financing needs.
Extracted from official company announcements. Not StockFin.ai's opinion.
⚖️ Peer Comparison — Chemicals & Petrochemicals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| Solar Industries India Limited | 1.57 L Cr | 132.3 | — | — | — |
| Pidilite Industries Limited | 1.49 L Cr | 75.7 | — | — | — |
| SRF Limited | 79,723 | 69.5 | — | — | — |
| Linde India Limited | 62,701 | 141.9 | — | — | — |
| Gujarat Fluorochemicals Limited | 40,793 | 89.6 | — | — | — |
| Navin Fluorine International Limited | 35,894 | 131.5 | — | — | — |
| Himadri Speciality Chemical Limited | 30,071 | 56.6 | — | — | — |
| Deepak Nitrite Limited | 24,911 | 33.3 | — | — | — |
| Atul Limited | 20,904 | 48.8 | — | — | — |
| Tata Chemicals Limited | 19,079 | -47.1 | — | — | — |
🔗 Peer Stock Analyses
⚠️ Risk Factors
Execution risk around timely commissioning of the CNT and super speciality carbon black facilities by FY27-FY28 remains a key monitorable, as delays could impact anticipated market entry. Input cost volatility in specialty chemicals and potential competitive pressures in the EV supply chain could pressure margins if demand growth slows. While capex is internally funded, sustained cash flow generation must be validated as scale ramps up.
📋 Recent Filings
-
🔴 Corporate Action 10 August 2026Himadri Speciality Chemical Limited allotted 13,576 equity shares of Re.1 each to eligible employees under its 2016 Employee Stock Option Plan on 10 A...
-
Announcement 21 July 2026Himadri Speciality Chemical Limited reported consolidated revenue of INR 1,432 Crores in Q1FY27, up 28% YoY, driven by strong performance across its i...
-
Announcement 16 July 2026Himadri Speciality Chemical Limited announced that the audio recording of its earnings conference call for the first quarter ended 30 June 2026, held ...
-
🟡 Board Meeting 15 July 2026Himadri Speciality Chemical Limited's board approved unaudited Q1 FY27 results and approved three capex projects: Rs 128 crore to expand Anthraquinone...
-
🔴 Financial Results 15 July 2026Himadri Speciality Chemical Limited announced board approval of capex projects including Rs **128 crores** anthraquinone/carbazole expansion, Rs **70 ...
-
Announcement 15 July 2026Himadri Speciality Chemical Limited disclosed its Monitoring Agency Report for Q1 FY2027, confirming that proceeds from a ₹341.8172 crore preferential...
-
share transfer 11 July 2026Himadri Speciality Chemical Limited received a SEBI-mandated certificate from S.K. Infosolutions confirming dematerialization of securities for the qu...
-
🔴 Announcement 10 July 2026Himadri Speciality Chemical Limited announced that ICRA upgraded its long-term rating from [ICRA]AA- (Positive) to [ICRA]AA (Stable) and revised the o...
-
Financial Results 24 June 2026Himadri Speciality Chemical Limited announced that its trading window will close on 1 July 2026 for designated persons and remain closed until 48 hour...
-
Announcement 20 June 2026Himadri Speciality Chemical Limited announced the opening of a new office in Mumbai on June 20, 2026, to strengthen its presence in the Western Region...
🧠 Analyst's Read
Himadri is executing a clear strategic pivot toward high-growth specialty chemicals with capital-intensive expansion plans, supported by improving operational margins and strong cash flow. Investors should monitor the phased commissioning of the CNT and carbon black projects, as their success will determine the pace of diversification into EV and semiconductor value chains.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-08-13.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when HSCL files new disclosures
Track HSCL filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track HSCL — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research